Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Revenue

Enorama Pharma AB had revenue of 1.57M SEK in the quarter ending March 31, 2026, with 250.33% growth. This brings the company's revenue in the last twelve months to 3.86M, down -76.25% year-over-year. In the year 2025, Enorama Pharma AB had annual revenue of 2.74M, down -82.63%.

• Revenue (ttm): 3.86M
• Revenue Growth: -76.25%
• P/S Ratio: 7.85
• Revenue / Employee: 771.20K
• Employees: 5
• Market Cap: 30.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.74M	-13.03M	-82.63%
Dec 31, 2024	15.77M	14.41M	1,061.12%
Dec 31, 2023	1.36M	-5.49M	-80.17%
Dec 31, 2022	6.85M	-5.95M	-46.50%
Dec 31, 2021	12.80M	8.33M	186.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error